A Bioequivalence Study of Sunitinib Malate Capsules.

NCT05800106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors
Renal Cell Carcinoma
Pancreatic Neuroendocrine Tumor

Interventions

DRUG: Sunitinib malate capsules generic product
DRUG: Sunitinib malate capsules reference product

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.